Palvella Therapeutics (PVLA) PT Raised to $97 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Ritu Baral raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $97.00 (from $65.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
